相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis
Georg Greiner et al.
HAEMATOLOGICA (2020)
Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase
Caitlin Carrigan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
Javier I. Munoz-Gonzalez et al.
BLOOD (2019)
Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia
Quang T Le et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Henry R. Maun et al.
CELL (2019)
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
Catherine R. Weiler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Clinical response to omalizumab in patients with hereditary α-tryptasemia
Lybil B. Mendoza Alvarez et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R. Sperr et al.
LANCET HAEMATOLOGY (2019)
Why the 20%+2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number
Jonathan J. Lyons et al.
GENETICS IN MEDICINE (2018)
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis
Nicole Naumann et al.
GENES CHROMOSOMES & CANCER (2018)
Hereditary Alpha Tryptasemia Genotyping and Associated Clinical Features
Jonathan J. Lyons
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2018)
First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease
Vito Sabato et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2018)
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis
Georg Greiner et al.
CLINICAL CHEMISTRY (2018)
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
S. Broesby-Olsen et al.
ALLERGY (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis
Theo Gulen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent et al.
CANCER RESEARCH (2017)
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+advanced systemic mastocytosis
M. Jawhar et al.
LEUKEMIA (2016)
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Jonathan J. Lyons et al.
NATURE GENETICS (2016)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical characteristics and risk profile of patients with elevated baseline serum tryptase
C. Fellinger et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease
G. Hoermann et al.
ALLERGY (2014)
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis
Philipp Erben et al.
ANNALS OF HEMATOLOGY (2014)
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
T. Gulen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Diagnostic Criteria and Classification of Mastocytosis in 2014
Cem Akin et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation
Theo Gülen et al.
Clinical and Translational Allergy (2013)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Factors influencing serum total tryptase concentrations in a general adult population
Arturo Gonzalez-Quintela et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Anaphylaxis and Mast Cell Disease: What Is the Risk?
Cem Akin
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
Mastocytosis and insect venom allergy
Patrizia Bonadonna et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mast cell activation syndrome: Proposed diagnostic criteria
Cem Akin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity
Franziska Rueff et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
K. Brockow et al.
ALLERGY (2008)
Tryptase haplotype in mastocytosis: Relationship to disease variant and diagnostic utility of total tryptase levels
Cem Akin et al.
CLINICAL IMMUNOLOGY (2007)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Diagnostic value of tryptase in anaphylaxis and mastocytosis
Lawrence B. Schwartz
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Elevated basal serum tryptase and hymenoptera venom allergy:: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy
G Haeberli et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease
WR Sperr et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Surrogate markers of disease in mastocytosis
C Akin et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
分享论文
